Literature DB >> 3110335

Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report.

M E Carter, D N Joyce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110335     DOI: 10.1007/bf01555453

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


× No keyword cloud information.
  5 in total

1.  Incessant ovulation--a factor in ovarian neoplasia?

Authors:  M F Fathalla
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

2.  Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report.

Authors:  P N Bamford; S J Steele
Journal:  Br J Obstet Gynaecol       Date:  1982-11

3.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.

Authors:  D W Cramer; W R Welch
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

4.  LH(hCG) receptor in benign and malignant tumors of human ovary.

Authors:  H Rajaniemi; A Kauppila; L Rönnberg; K Selander; P Pystynen
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1981

5.  Massive hyperstimulation and borderline carcinoma of the ovary. A possible association.

Authors:  M Atlas; J Menczer
Journal:  Acta Obstet Gynecol Scand       Date:  1982       Impact factor: 3.636

  5 in total
  4 in total

1.  Isolation, growth and characteristics of human ovarian surface epithelium.

Authors:  M Nakamura; H Katabuchi; T Ohba; Y Fukumatsu; H Okamura
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

3.  Follicular stimulation for high tech pregnancies: are we playing it safe?

Authors:  S Fishel; P Jackson
Journal:  BMJ       Date:  1989-07-29

Review 4.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.